$1.97
Amylyx Pharmaceuticals is a biotechnology business based in the US. Amylyx Pharmaceuticals shares (AMLX) are listed on the NASDAQ and all prices are listed in US Dollars. Amylyx Pharmaceuticals employs 384 staff and has a trailing 12-month revenue of around $398 million.
Our top picks for where to buy Amylyx Pharmaceuticals stock
How to buy Amylyx Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AMLX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Amylyx Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Amylyx Pharmaceuticals stock price (NASDAQ: AMLX)
Use our graph to track the performance of AMLX stocks over time.Amylyx Pharmaceuticals shares at a glance
Latest market close | $1.92 |
---|---|
52-week range | $1.58 - $23.95 |
50-day moving average | $1.83 |
200-day moving average | $9.47 |
Wall St. target price | $4.25 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.07 |
Is it a good time to buy Amylyx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Amylyx Pharmaceuticals price performance over time
Historical closes compared with the close of $1.92 from 2024-07-25
1 week (2024-07-19) | -4.95% |
---|---|
1 month (2024-06-26) | 4.92% |
3 months (2024-04-26) | 9.09% |
6 months (2024-01-26) | -87.52% |
1 year (2023-07-26) | -91.59% |
---|---|
2 years (2022-07-26) | -91.57% |
3 years (2021-07-22) | N/A |
5 years (2019-07-22) | N/A |
Amylyx Pharmaceuticals financials
Revenue TTM | $398 million |
---|---|
Gross profit TTM | $-74,213,000 |
Return on assets TTM | -12.31% |
Return on equity TTM | -21% |
Profit margin | -17.86% |
Book value | $4.77 |
Market Capitalization | $137.4 million |
TTM: trailing 12 months
Amylyx Pharmaceuticals share dividends
We're not expecting Amylyx Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- Sanofi ADR (SNY.US) (3.98% forward annual dividend yield)
Amylyx Pharmaceuticals share price volatility
Over the last 12 months, Amylyx Pharmaceuticals's shares have ranged in value from as little as $1.575 up to $23.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amylyx Pharmaceuticals's is -0.639. This would suggest that Amylyx Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Amylyx Pharmaceuticals has bucked the trend.
To put Amylyx Pharmaceuticals's beta into context you can compare it against those of similar companies.
- Cortexyme (CRTX.US): 1.3958
- Alector (ALEC.US): 0.724
- Sanofi ADR (SNY.US): 0.408
Amylyx Pharmaceuticals overview
Amylyx Pharmaceuticals, Inc. , a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questions
nullWhat percentage of Amylyx Pharmaceuticals is owned by insiders or institutions?
Currently 14.224% of Amylyx Pharmaceuticals shares are held by insiders and 88.478% by institutions. How many people work for Amylyx Pharmaceuticals?
Latest data suggests 384 work at Amylyx Pharmaceuticals. When does the fiscal year end for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals's fiscal year ends in December. Where is Amylyx Pharmaceuticals based?
Amylyx Pharmaceuticals's address is: 43 Thorndike Street, Cambridge, MA, United States, 02141 What is Amylyx Pharmaceuticals's ISIN number?
Amylyx Pharmaceuticals's international securities identification number is: US0321085088 What is Amylyx Pharmaceuticals's CUSIP number?
Amylyx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 032108508
More guides on Finder
-
Options trading strategies for beginners
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question